Literature DB >> 17599696

Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Miguel Angel Riudavets1, Diego Iacono, Susan M Resnick, Richard O'Brien, Alan B Zonderman, Lee J Martin, Gay Rudow, Olga Pletnikova, Juan C Troncoso.   

Abstract

This study focuses on the morphometric changes of neurons in asymptomatic Alzheimer's disease (AD), a state characterized by the presence of AD lesions in subjects without cognitive impairment. In autopsy brains, we used stereological methods to compare the cell body and nuclear volumes of anterior cingulate gyrus (ACG) and CA1 hippocampal neurons in asymptomatic AD subjects (n=9), subjects with AD dementia (AD, n=8), mild cognitive impairment (MCI, n=9), and age-matched controls (controls, n=9). In ACG, we observed a significant decrease in the neuronal volume of MCI and AD compared to controls; by contrast, no atrophy was present in asymptomatic AD. Moreover, we found a significant increase in nuclear volume in asymptomatic AD compared to controls (P<0.001), MCI (P<0.01) and AD (P<0.001) brains. Similar results were found in the CA1 region of the hippocampus. This nuclear hypertrophy may represent an early neuronal reaction to Abeta or Tau, or a compensatory mechanism which forestalls the progression of AD and allows the brain to resist the development of dementia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599696      PMCID: PMC2694127          DOI: 10.1016/j.neurobiolaging.2007.05.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  55 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Pictures in molecular medicine: contemplating Alzheimer's disease as cancer: a loss of cell-cycle control.

Authors:  K Herrup; Y Yang
Journal:  Trends Mol Med       Date:  2001-11       Impact factor: 11.951

3.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

4.  Size of neocortical neurons in control subjects and in Alzheimer's disease.

Authors:  M J Bundgaard; L Regeur; H J Gundersen; B Pakkenberg
Journal:  J Anat       Date:  2001-04       Impact factor: 2.610

Review 5.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

6.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.

Authors:  J L Price; A I Ko; M J Wade; S K Tsou; D W McKeel; J C Morris
Journal:  Arch Neurol       Date:  2001-09

7.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis.

Authors:  N Evangelou; D Konz; M M Esiri; S Smith; J Palace; P M Matthews
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

8.  Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging.

Authors:  C Kawas; S Gray; R Brookmeyer; J Fozard; A Zonderman
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

9.  Absence of cognitive impairment or decline in preclinical Alzheimer's disease.

Authors:  W P Goldman; J L Price; M Storandt; E A Grant; D W McKeel; E H Rubin; J C Morris
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

10.  Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.

Authors:  A Lorenzo; M Yuan; Z Zhang; P A Paganetti; C Sturchler-Pierrat; M Staufenbiel; J Mautino; F S Vigo; B Sommer; B A Yankner
Journal:  Nat Neurosci       Date:  2000-05       Impact factor: 24.884

View more
  56 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

2.  Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Authors:  Elliott J Mufson; Michael Malek-Ahmadi; Sylvia E Perez; Kewei Chen
Journal:  Neurobiol Aging       Date:  2015-10-20       Impact factor: 4.673

3.  Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Authors:  Joseph L Price; Daniel W McKeel; Virginia D Buckles; Catherine M Roe; Chengjie Xiong; Michael Grundman; Lawrence A Hansen; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Charles D Smith; Daron G Davis; Frederick A Schmitt; William R Markesbery; Jeffrey Kaye; Roger Kurlan; Christine Hulette; Brenda F Kurland; Roger Higdon; Walter Kukull; John C Morris
Journal:  Neurobiol Aging       Date:  2009-04-18       Impact factor: 4.673

4.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

5.  Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.

Authors:  Debra A Fleischman; Sue Leurgans; Konstantinos Arfanakis; Zoe Arvanitakis; Lisa L Barnes; Patricia A Boyle; S Duke Han; David A Bennett
Journal:  Brain Struct Funct       Date:  2013-08-17       Impact factor: 3.270

6.  Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).

Authors:  Richard J O'Brien; Susan M Resnick; Alan B Zonderman; Luigi Ferrucci; Barbara J Crain; Olga Pletnikova; Gay Rudow; Diego Iacono; Miguel A Riudavets; Ira Driscoll; Donald L Price; Lee J Martin; Juan C Troncoso
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 7.  Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?

Authors:  I Driscoll; J Troncoso
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

Review 8.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Characterizing the Molecular Architecture of Cortical Regions Associated with High Educational Attainment in Older Individuals.

Authors:  David Bartrés-Faz; Gabriel González-Escamilla; Lídia Vaqué-Alcázar; Kilian Abellaneda-Pérez; Cinta Valls-Pedret; Emilio Ros; Michel J Grothe
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

10.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.